Navigation Links
Neurologix Completes Additional $7 Million Financing
Date:12/6/2010

ny. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, or performance, as well as underlying assumptions and statements that are other than statements of historical fact. When used in this document, the words "expects," "promises," "anticipates," "estimates," "plans," "intends," "projects," "predicts," "believes," "may" or "should," and similar expressions, are intended to identify forward-looking statements. These statements reflect the current view of the Company's management with respect to future events. Many factors could cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, but not limited to, the following:

  • The Company is still in the development stage and has not generated any revenues. From inception through September 30, 2010, it incurred net losses and negative cash flows from operating activities of approximately $58 million and $43 million respectively. Management believes that the Company will continue to incur net losses and cash flow deficiencies from operating activities for the foreseeable future. Because it may take years to develop, test and obtain regulatory approval for a gene-based therapy product before it can be sold, the Company likely will continue to incur significant losses for the foreseeable future. Accordingly, it may never be profitable and, if it does become profitable, it may be unable to sustain profitability.
  • The Company will need to conduct future clinical trials for treatment of Parkinson's disease using NLX-P101. If the trials prove unsuccessful, future operations and the potential for profitability will be materially adversely affected and the business may not succeed.
  • There is no assurance as to when, or if, the Company will be able to successfully re
    '/>"/>

  • SOURCE Neurologix, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. New Details Presented at the World Parkinson Congress on Neurologixs Successful Phase 2 Trial of Gene Therapy for Parkinsons Disease
    2. Research Published in Science Translational Medicine Underscores Value of Depression Gene Therapy License Held by Neurologix
    3. Neurologix Reports Third Quarter 2010 Financial Results
    4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
    5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    6. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
    7. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
    8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
    9. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
    10. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
    11. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/19/2014)... , Dec. 19, 2014 In ... research and marketing communication tools are essential for ... competitive – consequently consumers, desires, preferences, and unmet ... environment, market research groups across all industries are ... communication tools. However, the adoption of new market ...
    (Date:12/19/2014)... , Dec. 18, 2014 Research and ... the addition of the "Micro Market Monitor: ... to their offering. ... treatment is progressing steadily, which has resulted in ... devices market. The main purpose of these dermatology ...
    (Date:12/19/2014)... Ky. , Dec. 18, 2014 Baptist Health ... States to receive full Atrial Fibrillation with Electrophysiology ... Care (SCPC). Atrial fibrillation is the most common ... that in some cases can lead to stroke and possible ... United States have atrial fibrillation and the numbers ...
    Breaking Medicine Technology:Study Uncovers New Tools and Techniques for Understanding Consumer Decision Making 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 3Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3
    ... Campbell Alliance, an inVentiv Health company and ... pharmaceutical and biotech industry, today announced the appointment ... Mr. Naeymi-Rad, formerly Chief Operating Officer, succeeds John ... years ago. (Photo: http://photos.prnewswire.com/prnh/20110908/CL64996 ...
    ... Campbell Alliance, an inVentiv Health ... the pharmaceutical and biotech industry, today announced executive promotions ... Earlier today, Campbell Alliance announced that Nader ... of Chief Executive Officer.  The firm is also making ...
    Cached Medicine Technology:Nader Naeymi-Rad Appointed CEO of Campbell Alliance 2Nader Naeymi-Rad Appointed CEO of Campbell Alliance 3Nader Naeymi-Rad Appointed CEO of Campbell Alliance 4Nader Naeymi-Rad Appointed CEO of Campbell Alliance 5Campbell Alliance Announces Executive Promotions and Organizational Changes 2Campbell Alliance Announces Executive Promotions and Organizational Changes 3Campbell Alliance Announces Executive Promotions and Organizational Changes 4Campbell Alliance Announces Executive Promotions and Organizational Changes 5Campbell Alliance Announces Executive Promotions and Organizational Changes 6
    (Date:12/20/2014)... Viejo, California (PRWEB) December 20, 2014 ... announced the release of a new plugin for Final ... Film Studios. , “TranSlice Volume 5 allows users to ... hand draw it.” Said Christina Austin, CEO of Pixel ... add level of professionalism while maintaining an easy to ...
    (Date:12/20/2014)... Today, Balfleet.com, one of the most ... offering 50%-70% off on its Mother of the ... mother of the bride dresses from Balfleet.com feature gorgeous ... accessible and takes pride in providing high quality dresses ... offering great discounts on our mother of the bride ...
    (Date:12/19/2014)... Sub Zero Ice Cream is partnering up with the Suncoast ... from 2pm-6pm at the Expo Center on the northeast corner ... Inquiries regarding time slots and signing up, email todd.subzeroicecream(at)gmail(dot)com. As ... Sub Zero Ice Cream & Yogurt will be offering all ... Sub Zero Ice Cream & Yogurt , Sub Zero ...
    (Date:12/19/2014)... (PRWEB) December 19, 2014 SuperCloset raises ... SuperClone Rooms. SuperCloset continues to offer indoor growers the ... one of the new SuperClone Rooms with the award ... and turnkey indoor hydroponic grow room setup. , The ... world, SuperCloset’s SuperPonic SuperCloner 50 . ...
    (Date:12/19/2014)... (PRWEB) December 20, 2014 The Medspa ... new injectable filler from respected cosmetic brand Juvéderm. Voluma ... naturally with age. The Medspa at Hendrick is pleased ... in skin care technology to its clients. , Voluma ... to be FDA-approved to treat the mid-face and cheek ...
    Breaking Medicine News(10 mins):Health News:Pixel Film Studios released a new transition entitled TranSlice Volume 5 exclusively for Final Cut Pro X 2Health News:Balfleet.com is Offering 50%-70% Off of its Mother of the Bride Dresses 2Health News:Shark Tank’s Sub Zero Ice Cream Sponsors Blood Drive 2Health News:SuperCloset Continues to Innovate with New Complete Indoor Grow Room Packages, The SuperClone Rooms are the Newest Addition to the Award Winning SuperRoom Lineup 2Health News:Breakthrough New Injectable Dermal Filler Voluma XC Offered by The MedSpa at Hendrick 2
    ... the Nissan Quest,and their families can breathe easy when ... is thanks to micronAir(R) combination filters - a,product of ... on the Quest. The combination filters from micronAir ... the HVAC system, reducing offensive odors as well as,gaseous ...
    ... Amsterdam, November 6, 2007 Elsevier announced ... AG, headquartered in Leverkusen, Germany, has signed an ... electronic format for the first time, EMBASE Classic ... 43 Excerpta Medica Abstract Journals published between 1947 ...
    ... vitamins and electrolytes offer healthiest ... benefits in new functional water, PLANO, Texas, Nov. ... punch, Snapple,s introduction of Antioxidant Water and,LYTeWater takes drinking water to ... smart solution that,improves energy, helps restore the body and supports a ...
    ... Micromet, Inc. (Nasdaq:,MITI), a biopharmaceutical company ... cancer, inflammation and autoimmune diseases,announced the publication ... mode of,action of Micromet,s bispecific BiTE antibody ... of Immunotherapy(1) and in Cancer Immunology,Immunotherapy(2), respectively. ...
    ... BioElectronics,Corporation, (Pink Sheets: BIEL), announced today that Michael ... Vice President of Sales. Mr. Seidenman is ... well versed in electro medicine devices. He brings ... device sales,management. Mr. Seidenman has launched many new ...
    ... Nov. 6 /PRNewswire-FirstCall/ - Lorus Therapeutics Inc.,(,Lorus,), a ... of pharmaceutical products and,technologies for the management of ... at 10:30 a.m. EST (Eastern Standard Time), Dr.,Aiping ... corporate overview of the,Company at the Acumen BioFin ...
    Cached Medicine News:Health News:Quality Control: Nissan Quest to Feature micronAir(R) Combination Cabin Air Filters 2Health News:EMBASE Classic makes inroads into pharmaceutical industry 2Health News:Snapple's New Antioxidant Water and LYTeWater Take Hydration to the Next Level 2Health News:Snapple's New Antioxidant Water and LYTeWater Take Hydration to the Next Level 3Health News:Micromet's BiTE(R) Antibodies Reveal Unique Mode of Action 2Health News:Micromet's BiTE(R) Antibodies Reveal Unique Mode of Action 3Health News:Micromet's BiTE(R) Antibodies Reveal Unique Mode of Action 4Health News:Micromet's BiTE(R) Antibodies Reveal Unique Mode of Action 5Health News:BioElectronics Corporation Announces Addition of Michael Seidenman, R.Ph. as Vice President of Sales 2Health News:Lorus announces presentation of corporate overview at the Rodman and Renshaw Annual Healthcare Conference 2
    ... combined with the ultimate space efficient ... the new Topcon Express Lane the ... Century practice environments: Ultimate Space EfficiencyComplete, ... in an 8' X 9' room ...
    ... For those who need to move their ... a handy portable solution. The IMAGEnet Portable System ... built-in flat panel monitor. This portable PC solution ... camera choices to be tailored to your multi-site ...
    ... Topcon combines the best 32-bit software package ... hardware offerings to bring you a fast ... cost efficient "mid-resolution" package takes advantage of ... adds the latest graphics capture technology and ...
    Inquire...
    Medicine Products: